MEDICAL PRODUCTS
Human Ultracell V IM
Human Ultracell V Oral
Human Citoplacell 3G
Revercell 3G
Cellorgane Multi-Complex 3G
Androcell 3G
Biofemin 3G
Bioenzym 3G
Celltox 3G
Mekenz H7 3G
Cellorgane Man
Cellorgane Woman
Formula 1 Skin & Muscle
Formula 2 Liver
Formula 3 Heart-Artery-Vein
Formula 4 Bone-Cartilage
Formula 5 Kidney - Nephrons
Formula 6 Lungs
Formula 7 Brain-Hypothalamus-Pituitary
Formula 8 Adrenal Gland
Formula 9 Thymus - Spleen
Formula 10 Pancreas
Formula 11 Esophagus-Stomach-Intestines
Formula 12 Thyroid
LOGGED IN
No one logged in.

Cellorgane® Multi-Complex 3G - Man

Multiorganic Cellular Revitalization Therapy Man

Problem

With age, organ function progressively decreases due to cell deterioration, caused mainly by oxidative stress; this generates vitality and quality of life losses. This organic sub function predisposes to chronic degenerative diseases.

Uses

  • Hepatic Deficiency
  • Cirrhosis
  • Arthritis and Osteoarthritis
  • Rheumatism
  • Anemia
  • Fatigue and Adynamia
  • Heart failure
  • Depression
  • Memory problems
  • Aging
  • Chronic and acute stress
  • Sexual decline
  • Type 2 Diabetes Mellitus

Man

  • Low libido
  • Andropause

Solution

The organic extracts of amino acids, enzymes and polypeptides create a revitalizing action of each organ through induction of "Autophagy”, disposal and recycling of intracellular debris, promoting cell renewal.
Multiorgan treatment that helps regulate various types of alterations and cell failures simultaneously with organic revitalization.

Composition

Oral CELLORGANE MAN Each 500-mg enteric coated tablet contains:
Opotherapic cell extracts: Embryo / Testes, pituitary gland, adrenal gland, brain, embryoblasts, Thymus, hypothalamus, liver, spleen, bone marrow, pancreas, kidney, lung, arteries, veins, capillaries, heart, spinal cord, muscle, cartilage, skin, eyeballs and mesoderm; Antioxidant enzyme complex: Superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione transferase; Maltodextrin and stabilizers.

Injectable CELLORGANE MAN
Each 750-mg Lyophilized Vial contains:
Opotherapic cell extracts: Embryo / Testes, Pituitary, Adrenal Gland, Brain, embryoblasts, Thymus, hypothalamus, liver, spleen, bone marrow, pancreas, kidney, lung, arteries, veins, capillaries, heart, spinal cord, muscle, cartilage , skin, eyeballs and mesoderm; stabilizers and Mannitol.

Each 10-ml/250-mg Solvent Vial contains:
Opotherapic cell extracts Placenta 10%, procaine 2%, Sodium chloride 0.9%; Enzyme complex: Superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione transferase, stabilizers and sufficient sterilized Water for injection.

Action Mechanisms

Formula components reach the cells directly or indirectly, in the case of oral products, by bloodstream, and are selectively incorporated into the cells through various means of cellular transport.
It acts revitalizing all the organs at the cellular level, improving its functionality and reducing the risk of degenerative diseases.

Contraindications

  • Allergies to animal proteins.
  • Allergy to any of its components.
  • Pregnancy and lactation.

Posology

Preventive / Revitalizing Treatment

Intramuscular: 2 ml daily for 5 days, two days off and restart 2 ml daily for 5 days, at the end of the injectable treatment should continue with Oral treatment for at least three months.

Orally: 2 tablets daily for 30 days. The tablets are taken with water always on an empty stomach (30 minutes before eating)
In cases of several pathologies (under control):

Orally: 2 tablets in the morning and 2 tablets (2 x 2) at night for at least six months. The tablets are taken with water always on an empty stomach (30 minutes before eating).

Intramuscular:
2 ml daily for 5 days, two days off and restart 2 ml daily for 5 days, evaluate results and continue with 2 ml daily for 5 days, two days off and restart 2 ml daily for 5 days for a total of 4 treatments of Cellorgane Multi-Complex.

It is suggested to repeat the treatment at 3 months after finishing the first block, having been evaluated by the doctor. At the end of the injectable treatment, continue with Oral treatment of 2 X 2 tablets morning and night for at least three months.

The tablets are taken with water always on an empty stomach (30 minutes before eating)

Note: The tablets are taken in the morning on an empty stomach and at night before dinner (30 minutes before meals).

Pathology:

Intramuscular:
2 ml daily for 5 days, two days off and restart 2 ml daily for 5 days, evaluate results and continue with 2 ml daily for 5 days, two days off and restart 2 ml daily for 5 days. Continue applications making a total of 4 cases.

It is suggested to repeat the treatment at 3 months after finishing the first block, prior assessment by the treating physician.

Orally: 2 Tablets in the morning and 2 tablets (2 x 2) at night for at least six months. The tablets are taken with water always on an empty stomach (30 minutes before eating).

Posology 2

Annual Revitalization
Preventive Program 12 Months Symptomatic patients.
Combined monthly dosage via intramuscular and oral:

Intramuscular: injecting 2 ml intraday until 5 applications per month for 12 continuous months.

Orally: Take 1 tablet in the morning and one at night (1 X 1) for 12 continuous months.

Begin preventive therapy with Cellorgane Multi-Complex® # 1 to end on month # 12 with Cellorgane Multi-Complex® man or woman according to gender.
Preventive Program 12 Months Asymptomatic patients.
Intramuscular or oral dosage chosen by the therapist according to patient history.

Intramuscular: intraday intramuscular injection of 2 ml each month.

Orally: Take 1 tablet in the morning and one (1 X 1) at night for 12 consecutive months. Begin preventive therapy Cellorgane Multi-Complex® # 1 to end on month #12 with Cellorgane Multi-Complex® man or woman according to gender.

Note:
The dose may be increased according to the clinical picture of the patient and the physician's discretion; the results depend on the completion of treatment.

Adjuvant treatment with:

Bronchodilators

Aminophylline, Theophylline, Tiotropium, albuterol, levalbuterol
Antihistamines Loratadine, Desloratadine, cetirizine, levocetirizine
Antihypertensive and heart failure
  • Calcium antagonists: Nifedipine
  • ACE inhibitors: Enalapril, Captopril
  • ARB-II: losartan, candesartan
  • Beta-blockers: Atenolol, Metoprolol, Carvedilol, Bisoprolol
  • Thiazide diuretics: Hydrochlorothiazide, chlorthalidone, indapamide, xipamide, Ameride (thiazide & K+ saver)
Hypoglycemic
  • Biguanides: Metformin
  • Inhibitors of alpha-glucosidase: Acarbose
  • Sulfonylureas: glibenclamide, glimepiride, glyburide and Tolazamide
  • Injectable drugs (like GLP-1): Sitagliptin, Saxagliptin, and linagliptin
  • Meglitinides: Repaglinide, nateglinide
  • SGLT2 Inhibitors: Dapagliflozin
  • Thiazolidinediones: Pioglitazone
  • DPP IV inhibitors: Sitagliptin and vildagliptin
  • Injectable insulin
Diuretics
  • Loop diuretics: Furosemide, Amiloride
  • Thiazide and analogues: IDEM (above)
  • K + Savers: Spironolactone
  • Osmotic: Mannitol
Statins

Selective, competitive inhibitors of HMG-CoA reductase: atorvastatin, simvastatin, pravastatin

Coronary vasodilators
  • Antianginal: Calcium antagonists - Nifedipine
  • Competitive antagonist of beta 1 and beta 2 adrenergic receptors: Propranolol
Heart failure Digitalis: Digoxin
Venous insufficiency
  • Venotonic and vasculoprotective drugs: Diosmin, Hidrosmin, Horse Chestnut Seed
Alzheimer
  • Reversible inhibitor of the enzyme acetylcholinesterase: Donepezil, Galantamine
  • NMDA receptor antagonist: Memantine
  • Neurometabolic stimulator: Piracetam
  • Porcine-brain derived peptide preparation: Cerebrolysin
  • Cholinesterase inhibitors: Rivastigmine
Hormone Replacement Therapy Estrogen, Progesterone, Testosterone, Prasterone, Mesterolone, Fluoxymesterone
Chemotherapy
  • Methotrexate, actinomycin D, vincristine, ifosfamide, Raltitrexed, Bevacizumab, Irinotecan, oxaliplatin, cetuximab, capecitabine, carboplatin, tamoxifen, cisplatin, Megestrol
  • Gestonorone, Anastrozole, Paclitaxel, Vinorelbine, Trastuzumab, leuprorelin, Diethylstilbestrol, Nilutamide, epirubicin, among others
Antidepressants
  • Selective serotonin reuptake inhibitors (SSRI): paroxetine, sertraline, fluoxetine, citalopram, escitalopram
  • Serotonin–norepinephrine reuptake inhibitors (SNRIs): venlafaxine, duloxetine, Desvenlafaxine
  • NaSSA: Mirtazapine
  • Tricyclic: amitriptyline, clomipramine, imipramine
  • MAOIs: Moclobemide
  • Serotonin–norepinephrine reuptake inhibitor (SNRI): Reboxetine
  • Dopamine-norepinephrine reuptake inhibitor (DNRI): Bupropion
Osteoporosis Zoledronic acid, bisphosphonates: risedronate, alendronate
Arthritis, Osteoarthritis, Pain relievers and anti-inflammatory
  • NSAIDs: ketorolac, paracetamol, diclofenac, indomethacin, Etoricoxib, diclofenac, misoprostol, etc. Opioids: Tramadol, morphine, buprenorphine, etc. Neuromodulators: Pregabalin
  • Gabapentin, Duloxetine. Corticosteroids: Dexamethasone, hydrocortisone, methylprednisolone, etc.
  • Corticosteroids: Betamethasone, Prednisone
Osteoarthritis Chondroitin, Glucosamine
Anti-anemic Iron
Renal impairment Recombinant erythropoietin, Furosemide, Amino Acids
Erectile dysfunction (ED) cyclic GMP-specific phosphodiesterase type 5 (PDE5): Sildenafil
Immunomodulators Interferon alfa
Antibiotics Beta-lactams, aminoglycosides, cephalosporins, macrolides
Intestinal motility regulators Cisapride, metoclopramide, Trimebutine, Pinaverium
Antacids Omeprazole, famotidine, pantoprazole, ranitidine
Stool softeners Fiber, Sennosides, Docusate
Digestive enzymes Bromelain, papain, pepsin, trypsin, lipase, Pancreatin

Alpha-blockers

Tamsulosin, terazosin, doxazosin, alfuzosin

Who We Are

Biocell Ultravital™ researches and develops innovative, 100% natural, pharmaceutical-grade bioproducts, on an exclusive basis worldwide. These products optimise cell nutrition and energy, producing a preventative and curative action which, in addition to treating pre-symptoms and symptoms by means of cell renewal, refuels and corrects the cell structure of tissues and organs, preventing the appearance of the functional stress loads which give rise to poor cell formation, degenerative diseases, and their after-effects.

Policies

Product developed under pharmaceutical control according to European CE standards. Made in the EC by Biocell Laboratory France, licensed and authorized by Biocell Ultravital GmbH, Switzerland.

Privacy

This website is governed by applicable laws and government regulations. Please see our Privacy Policy.
Use of this site constitutes your consent to application of such laws and regulations.

© 2019 Biocell Ultravital